170617 ⎘
Assays involving biological materials from specific organisms or of a specific nature; Enzymes; Proenzymes; Transferases (2.); Glycosyltransferases (2.4); Hexosyltransferases (general) (2.4.1) with definite EC number (2.4.1.-)
Sub-classes:ANTI-TUMOR ANTIBODIES
#2COMPOSITION FOR DIAGNOSING COGNITIVE DYSFUNCTION OF COMPANION ANIMAL BY USING NASAL FLUID
#3DISCOVERING NEW XENOBIOTIC SUBSTRATES OF AN UDP-GLYCOSYLTRANSFERASE WITH A HIGH-THROUGHPUT METHOD
#4Prevention and treatment of depressive disorders and conditions promoted by protease containing plasma extracellular vesicles (PCpEV)
#5Lung Cancer Prediction and Uses Thereof
#6Cell Selection Methods and Related Compositions
#7L-FUCOSE AND ANTI-ANDROGEN RECEPTOR THERAPY FOR TREATMENT OF CANCER
#8Compositions and methods for capturing exosomes
#9Methods and materials for identifying and treating membranous nephropathy
#10Chemoenzymatic synthesis of trehalose analogues
#11Glycosylation modification of bioactive compounds and drugs by plant glycosyltransferases (UGTs)
#12Methods for detecting and for treating pancreatic cancer
#13COMPOSITIONS AND METHODS FOR CAPTURING EXOSOMES
#14Methods for treating testosterone deficiency in men and methods for precise dosing of UGT2B17 substrate drugs
#15Chemoenzymatic synthesis of trehalose analogs
#16Method of detecting the level of a glycan
#17BIOMARKERS USEFUL FOR DETERMINING RESPONSE TO PD-1 BLOCKADE THERAPY
#18Helicobacter pylori α-1,3 fucosyltransferase gene and protein with improved soluble protein expression and activity, and thereof application for synthesis of α-1,3 fucosyloligosaccharide
#19Method for evaluating cell populations
#20Ras pathways as markers of protection against HIV and methods to improve vaccine efficacy
#21COMPOSITIONS AND METHODS FOR CAPTURING EXOSOMES
#22Method for analyzing PSA, and a method for distinguishing prostate cancer from prostatic hypertrophy using that method for analyzing PSA
#23BIOMARKERS FOR STROKE DIAGNOSIS
#24Crystal structure of bifunctional transglycosylase PBP1b from and inhibitors thereof
#25Chemoenzymatic synthesis of trehalose analogs
#26Aptamers for clostridium difficile diagnostics
#27COMPOSITIONS AND METHODS FOR TREATING CARDIAC HYPERTROPHY
#28METHOD FOR TREATING CELL PROLIFERATIVE DISORDER BY INHIBITING C1GALT1 EXPRESSION
#29Methods and kits for detection of O-GlcNAc and N-GlcNAc modification of peptides and proteins
#30Method of production of recombinant sucrose synthase, use thereof in the manufacture of kits for determination of sucrose, production of adpglucose and production of transgenic plants whose leaves and storage organs accumulate high contents of adpglucose and starch
#31Method for analyzing PSA, and a method for distinguishing prostate cancer from prostatic hypertrophy using that method for analyzing PSA
#32Aptamers for diagnostics
#33GENE AND POLYPEPTIDE RELATING TO BREAST CANCER
#34CORE 2GLCNAC-T INHIBITORS
#35Method for evaluating cell populations
#36Compositions and methods for measuring 3,6-L-AHG transferase activity and 3,6-L-AHG
#37METHODS RELATING TO OLANZAPINE PHARMACOGENETICS
#38Core 2 GlcNAc-T inhibitors
#39CRYSTAL STRUCTURE OF BIFUNCTIONAL TRANSGLYCOSYLASE PBP1B FROM E. COLI AND INHIBITORS THEREOF
#40METHOD FOR IMPROVING THE PHARMACOKINETICS OF DRUGS METABOLIZED BY UGT2B10
#41Modulators of UDP-glucose ceramide glucosyltransferase for treating acne or hyperkeratinization
#42Method of production of recombinant sucrose synthase, use thereof in the manufacture of kits for determination of sucrose, production of adpglucose and production of transgenic plants whose leaves and storage organs accumulate high contents of adpglucose and starch
#43Diagnostic Methods and Genetic Markers for Alzheimer Disease
#44Method for evaluating cell populations
#45Assays and methods using biomarkers
#46Core 2 glcnac-t inhibitors
#47Assays and methods using biomarkers
#48Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
#49Methods and systems for evaluating health risk factors by measurement of DNA damage and DNA repair
#50Multiple sclerosis therapy and diagnosis
#51Compositions for treating dental caries caused by streptococcus mutans infection
#52Compositions and methods for inhibiting mucin-type O-linked glycosylation
#53Selectable gene marker system based on expression of N-acetyllactosaminide 3-α galactosyltransferase
#54Use of inhibitors of glycogen synthase-3 to augment CD28 dependent -T-cell responses